Inogen, Inc INGN
5.36
0.13
2.49%
as of 25 Sep
- Market cap
- $138.8M
- P/E
- 0.0×
Follow INGN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(13.27%) | (12.43%) | (13.07%) | (13.14%) | |
| (8.28%) | (7.65%) | (8.38%) | (8.23%) | ||
ROIC |
(27.77%) | (26.45%) | (27.90%) | (28.35%) | |
Return on Tangible Assets |
(14.41%) | (13.29%) | (15.28%) | (15.86%) | |
Average Days of Receivables |
42.46 | 40.68 | 43.48 | 47.55 | |
Free Cash Flow per Share |
(0.60) | (0.55) | (0.17) | (0.29) | |
Free Cash Flow |
(16.14) | (14.71) | (4.53) | (7.86) | |
Capital Expenditures |
(2.85) | (3.50) | (3.42) | (5.34) | |
Piotroski F-Score |
5.00 | 4.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(4.13%) | (3.58%) | (0.38%) | (0.89%) | |
Accounts Receivable Turnover |
9.18 | 10.19 | 8.96 | 8.36 | |
Accounts Payable Turnover |
6.26 | 6.36 | 5.71 | 5.26 | |
Inventory Turnover |
7.92 | 7.66 | 7.64 | 7.43 | |
Average Days of Payables |
65.13 | 63.73 | 60.97 | 73.66 | |
Days of Inventory on Hand |
47.74 | 48.76 | 46.60 | 53.15 | |
Tax Rate |
(0.03) | (0.03) | (0.03) | (0.03) | |
Research and Development Expense of Revenue |
5.76% | 5.56% | 5.82% | 5.96% | |
Selling, General and Administrative Expense of Revenue |
48.30% | 47.34% | 47.56% | 47.25% | |
Share Based Compensation of Revenue |
2.28% | 2.30% | 2.22% | 2.06% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.52 | 0.49 | 0.04 | 0.10 | |
Depreciation/Fixed assets |
0.55 | 0.57 | 0.60 | 0.62 | |
Capex/Depreciation |
(0.14) | (0.17) | (0.17) | (0.27) | |
Revenue per Share |
12.82 | 13.11 | 12.86 | 13.10 | |
Operating CF per Share |
(0.49) | (0.42) | (0.04) | (0.09) | |
Capex per Share |
(0.11) | (0.13) | (0.13) | (0.20) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 | |
Net Profit Margin |
(7.31%) | (6.52%) | (7.08%) | (6.94%) |
Columns are period end dates